CoChat

Plasma Biomarkers Differentiate Parkinson’s Disease From Atypical Parkinsonism Syndromes

Open access
Lin, Chin-Hsien, Yang, Shieh-Yueh, Horng, Herng-Er, Yang, Che-Chuan, Chieh, Jen-Jie, Chen, Hsin-Hsien, Liu, Bing-Hsien, Chiu, Ming-Jang · 2018 · Frontiers in Aging Neuroscience
Cited by 69

The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.

Abstract

Objective: Parkinson’s disease (PD) has significant clinical overlaps with atypical Parkinsonism syndromes (APS), which have a poorer treatment response and a more aggressive course than PD. We aimed to identify plasma biomarkers to differentiate PD from APS. Methods: Plasma samples (n=204) were obtained from healthy controls and from patients with PD, dementia with Lewy bodies (DLB), multiple system atrophy (MSA), progressive supranuclear palsy (PSP), corticobasal degeneration (CBD), or frontotemporal dementia with (FTD-P) or without parkinsonism. We measured plasma levels of a-synuclein, total tau, p-Tau181, and amyloid beta 42 (Abeta42) by immunomagnetic reduction-based immunoassay. Results: Plasma a-synuclein level was significantly increased in patients with PD and APS when compared with controls and FTD without parkinsonism (p<0.01). Total tau and p-Tau181 were significantly increased in all disease groups compared to controls, especially in patients with FTD (p<0.01). A multivariate and receiver operating characteristic (ROC) curve analysis revealed that a cut-off value for Abeta42 multiplied by p-Tau181 for discriminating patients with FTD from patients with PD and APS was 92.66 (pg/ml)2, with an area under the curve (AUC) of 0.932. An a-synuclein cut-off of 0.1977 pg/ml could separate FTD-P from FTD without parkinsonism (AUC 0.947). In patients with predominant parkinsonism, an a-synuclein cut-off of 1.388 pg/ml differentiated patients with PD from those with APS (AUC 0.87). Conclusions: Our results suggest that integrated plasma biomarkers improve the differential diagnosis of PD from APS (PSP, CBD, DLB and FTD-P).

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3389/fnagi.2018.00123

Cites

10 of 10 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 10 references

Cited by

See all 69

Metadata

Authors
Lin, C.-H., Yang, S.-Y., Horng, H.-E., Yang, C.-C., Chieh, J.-J., Chen, H.-H., Liu, B.-H., & Chiu, M.-J.
Venue
Frontiers in Aging Neuroscience
Published
2018-04-27
Volume
10
Pages
123-123
ISSN
1663-4365 (ISSN-L)
OpenAlex
W2801463155
Cited by
69
References
10
FWCI
3.85
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Plasma Biomarkers Differentiate Parkinson’s Disease From Atypical Parkinsonism Syndromes. https://app.cochat.ai/papers/10.3389/fnagi.2018.00123
The paper
Lin, C.-H., Yang, S.-Y., Horng, H.-E., Yang, C.-C., Chieh, J.-J., Chen, H.-H., Liu, B.-H., & Chiu, M.-J. (2018). Plasma Biomarkers Differentiate Parkinson’s Disease From Atypical Parkinsonism Syndromes. Frontiers in Aging Neuroscience. https://doi.org/10.3389/fnagi.2018.00123

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.